In conclusion, modulation of PGC-1α protein in mitochondrial biogenesis inhibits inflammatory response in RA, whereas AMPK, a key protein in sensing energy changes, has been widely used in the clinic as an interventional target (150). This evidence concerns the gene PPARGC1A and rheumatoid arthritis.